Zobrazeno 1 - 10
of 100
pro vyhledávání: '"ActiTest"'
Publikováno v:
Genel Tıp Dergisi, Vol 26, Iss 3, Pp 74-79 (2016)
Amaç: Bu çalışmada kronik hepatit B KHB ’de karaciğer biyopsisinde saptanan fibrozis ve inflamasyon derecesi referans alınarak fibrotestin FT fibrozisi ve actitestin AT nekroinflamatuar aktiviteyi belirlemedeki duyarlılığının araştırı
Externí odkaz:
https://doaj.org/article/0a17a8d7d34541f5a297d6d90298a186
Publikováno v:
Aktualʹnaâ Infektologiâ, Vol 2, Iss 3.04, Pp 59-64 (2014)
Liver fibrosis — a natural consequence of almost all liver diseases of any origin. We are faced with a number of standard stereotype processes that take place in the liver tissue. Mostly it is the processes of chronic inflammation, which oppose the
Externí odkaz:
https://doaj.org/article/093fd2c841354fb29868acb7bd4c66d7
Publikováno v:
Морфологія, Vol 7, Iss 3, Pp 33-36 (2013)
Background. Liver cirrhosis is the most often cause of the portal hypertension syndrome development, though structural and morphological liver remodeling usually begins on the stage of chronic hepatitis. Morphologic patterns of the development of por
Externí odkaz:
https://doaj.org/article/739a825a88fd46ed9cde9a510d91c1c8
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 53, Iss 3, Pp 470-475 (2010)
Aims: FibroTest and ActiTest are noninvasive tests used in determining the level of fibrosis and the degree of necroinflammatory activity in the liver. In our study, we aimed to investigate whether these tests could be alternative to liver biopsy. Ma
Externí odkaz:
https://doaj.org/article/5a2b49288b954d10a9663a9eddeaa685
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 11, Iss 1, Pp 1-19 (2005)
This review summarized the diagnostic value of fibrosis biomarkers and the efficacy of anti-viral treatments on fibrosis progression. Non-invasive biomarkers can facilitate the screening and management of chronic hepatitis C and B. Screening for sign
Externí odkaz:
https://doaj.org/article/e8844f72fa324e93adf48be636b155e0
Autor:
Małgorzata Aniszewska, Magdalena Pluta, Maria Pokorska-Śpiewak, Barbara Kowalik-Mikołajewska, Magdalena Marczyńska
Publikováno v:
Clinical and Experimental Hepatology
Aim of the study Was to evaluate liver disease severity in children with chronic viral hepatitis using the FibroTest and ActiTest (FT/AT), and compare the results with the liver biopsy. Material and methods The study included 11 treatment-naive child
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chen Sheng-Hung, Li Yu-Fen, Lai Hsueh-Chou, Kao Jung-Ta, Peng Cheng-Yuan, Chuang Po-Heng, Su Wen-Pang, Chiang I-Ping
Publikováno v:
BMC Gastroenterology, Vol 12, Iss 1, p 105 (2012)
Abstract Background Previous research has shown variation in the effects of patient factors, including hepatic necroinflammatory activity, on liver stiffness measurement (LSM). This prospective study attempts to identify explanatory factors for LSM i
Externí odkaz:
https://doaj.org/article/ce9818c1841c47f586b755249b687f09
Autor:
Irena Ciećko-Michalska, Tomasz Mach, Małgorzata Szczepanek, Iga Wierzbicka-Tutka, Janina Zahradnik-Bilska
Publikováno v:
Archives of Medical Sciences. Atherosclerotic Diseases
IntroductionNonalcoholic fatty liver disease (NAFLD) is one of the most common causes of abnormal liver enzymes in adult patients consulted by hepatologists. Due to the high prevalence of this disease, most often associated with obesity, it is necess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6db60f6c94b41370ace98173846fa14b
https://ruj.uj.edu.pl/xmlui/handle/item/128617
https://ruj.uj.edu.pl/xmlui/handle/item/128617
Autor:
Yakoob, Rafie, Bozom, Issam Al, Thandassery, Ragesh Babu, Rahman, Mohamed Osman Abdel, Derbala, Moutaz F., Mohannadi, Muneera J. Al, John, Anil K., Sharma, Manik, Wani, Hamidulla, Kaabi, Saad Al
Publikováno v:
Annals of Gastroenterology : Quarterly Publication of the Hellenic Society of Gastroenterology
Background The aim of this study was to compare noninvasive biomarkers, FibroTest and ActiTest in predicting fibrosis stage and inflammation grade in chronic hepatitis C (CHC) patients with liver biopsy (LB). Methods In 107 patients with CHC, levels